Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long-Term Administration of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Reduces Arterial FDG Uptake.

Literature DB >> 31806185

Long-Term Administration of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Reduces Arterial FDG Uptake.

Charalambos Vlachopoulos, Iosif Koutagiar, Ioannis Skoumas, Dimitrios Terentes-Printzios, Evangelos Zacharis, Genovefa Kolovou, Kimon Stamatelopoulos, Loukianos Rallidis, Niki Katsiki, Helen Bilianou, Evangelos Liberopoulos, Antigoni Miliou, Pavlos Kafouris, Aleksandros Georgakopoulos, Vasiliki Gardikioti, Dimitrios Tousoulis, Constantinos D Anagnostopoulos.

Abstract

Entities: Chemical

Year: 2019 PMID： 31806185 DOI： 10.1016/j.jcmg.2019.09.024

Source DB: PubMed Journal: JACC Cardiovasc Imaging ISSN： 1876-7591

Keyword Cloud
Cited

× No keyword cloud information.

3 in total

1. Lymphoma Severity and Type Are Associated With Aortic FDG Uptake by ¹⁸F-FDG PET/CT Imaging.

Authors: Charalambos V Vlachopoulos; Iosif P Koutagiar; Alexandros T Georgakopoulos; Anastasia G Pouli; Anastasia Κ Sioni; Stavroula Ε Giannouli; Spiros D Chondropoulos; Ioanna Ε Stergiou; Eirini G Solomou; Dimitrios G Terentes-Printzios; Ioannis G Karakitsios; Pavlos P Kafouris; Anastasios Gaitanis; Nikoletta K Pianou; Aikaterini Petrocheilou; Constantina I Aggeli; Euaggelia Stroumpouli; Theodoros P Marinakis; Michael Voulgarelis; Dimitrios M Tousoulis; Constantinos D Anagnostopoulos
Journal: JACC CardioOncol Date: 2020-12-15

Review 2. Proprotein Convertase Subtilisin/Kexin Type 9 and Inflammation: An Updated Review.

Authors: Na-Qiong Wu; Hui-Wei Shi; Jian-Jun Li
Journal: Front Cardiovasc Med Date: 2022-02-18

3. Time-related aortic inflammatory response, as assessed with ¹⁸F-FDG PET/CT, in patients hospitalized with severely or critical COVID-19: the COVAIR study.

Authors: Charalambos Vlachopoulos; Dimitrios Terentes-Printzios; Paraskevi Katsaounou; Eirini Solomou; Vasiliki Gardikioti; Dimitrios Exarchos; Dimitrios Economou; Georgia Christopoulou; Antonios-Dimosthenis Kalkinis; Pavlos Kafouris; Alexios Antonopoulos; Georgios Lazaros; Anastasia Kotanidou; Ioannis Datseris; Konstantinos Tsioufis; Constantinos Anagnostopoulos
Journal: J Nucl Cardiol Date: 2022-05-02 Impact factor: 3.872

3 in total

Long-Term Administration of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Reduces Arterial FDG Uptake.

1. Lymphoma Severity and Type Are Associated With Aortic FDG Uptake by 18F-FDG PET/CT Imaging.

Review 2. Proprotein Convertase Subtilisin/Kexin Type 9 and Inflammation: An Updated Review.

3. Time-related aortic inflammatory response, as assessed with 18F-FDG PET/CT, in patients hospitalized with severely or critical COVID-19: the COVAIR study.

1. Lymphoma Severity and Type Are Associated With Aortic FDG Uptake by ¹⁸F-FDG PET/CT Imaging.

3. Time-related aortic inflammatory response, as assessed with ¹⁸F-FDG PET/CT, in patients hospitalized with severely or critical COVID-19: the COVAIR study.